Â Mumbai-headquartered drug firm, Ajanta Pharma has launched blood pressure lowering tablet in the US market. The medicine has been launched in four strengths 5mg+20mg, 5mg+40mg, 10mg+20mg and 10mg+40mg. The launch is part of growing portfolio of products that the company has developed for the US market.Â Â
Company said, âafter the approval of the United States Food and Drug Administration (USFDA), the company has launched Amlodipine + Olmesartan Medoxomil tablets in the US market through its arm Ajanta Pharma USA Inc.â
The company’s product is a generic version of Daiichi Sankyo Inc’s Azor tablets, it added.
In total, the company has 29 Abbreviated New Drug Applications (ANDA) of which 16 are final ANDA app.